These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3217913)

  • 1. Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome.
    Grau E; Oliver A; Félez J; Barceló P; Fernandez C; Ballarin JA; Fontcuberta J; Rutllant ML
    Thromb Haemost; 1988 Oct; 60(2):137-40. PubMed ID: 3217913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
    Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V; Triolo L; De Martini D; Ferrelli R; Mori R; Leone G
    J Lab Clin Med; 1987 May; 109(5):550-5. PubMed ID: 3572202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P; Moulonguet-Doleris L; Costa JM; Aiach M
    Thromb Haemost; 1991 Jan; 65(1):20-4. PubMed ID: 2024235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the protein C-protein S system in glomerulopathies and nephrotic syndrome].
    Rostoker G; Gouault-Heilmann M; Levent M; Lang P; Robeva R; Lagrue G
    Nouv Rev Fr Hematol (1978); 1986; 28(6):359-63. PubMed ID: 2951650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activities of antithrombin III and heparin cofactor II in patients with pathologic blood coagulation conditions].
    Hirokawa S; Kaji T; Tazawa K; Fujimaki M; Hayashi T; Niiya K; Sakuragawa N
    Rinsho Ketsueki; 1992 Mar; 33(3):281-7. PubMed ID: 1578630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R; Saatçi U; Bakkaloğlu A; Beşbaş N; Başsoy Y
    Turk J Pediatr; 1992; 34(1):15-20. PubMed ID: 1509525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of heparin cofactor II deficiency in patients with a history of venous thrombosis.
    Lopaciuk S; Bykowska K; Kopeć M
    Pol J Pharmacol; 1996; 48(1):109-11. PubMed ID: 9112638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.
    Vaziri ND; Paule P; Toohey J; Hung E; Alikhani S; Darwish R; Pahl MV
    Arch Intern Med; 1984 Sep; 144(9):1802-3. PubMed ID: 6477000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA; Moia M; Rivolta E; Ponticelli C; Mannucci PM
    Thromb Haemost; 1999 Sep; 82(3):1020-3. PubMed ID: 10494757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis.
    Bertina RM; van der Linden IK; Engesser L; Muller HP; Brommer EJ
    Thromb Haemost; 1987 Apr; 57(2):196-200. PubMed ID: 3603411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma heparin cofactor II, protein C and antithrombin in elective surgery.
    Andersson TR; Berner NS; Larsen ML; Odegaard OR; Abildgaard U
    Acta Chir Scand; 1987 Apr; 153(4):291-6. PubMed ID: 3630527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylactic use of concentrated antithrombin III preparation in children with nephrotic syndrome].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1163-9. PubMed ID: 8264106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen--relationship with physiological variables and establishment of reference ranges.
    Rodeghiero F; Tosetto A
    Thromb Haemost; 1996 Aug; 76(2):226-33. PubMed ID: 8865536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y; Shiga S; Tohyama K; Shimatsu A; Ichiyama S
    Rinsho Byori; 2000 Sep; 48(9):867-71. PubMed ID: 11051806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III and the nephrotic syndrome.
    Jørgensen KA; Stoffersen E
    Scand J Haematol; 1979 May; 22(5):442-8. PubMed ID: 472663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of plasma protein C in nephrotic syndrome.
    Pabinger-Fasching I; Lechner K; Niessner H; Schmidt P; Balzar E; Mannhalter C
    Thromb Haemost; 1985 Feb; 53(1):5-7. PubMed ID: 3838827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.